Corporate Finance

Marriott's luxury brand EDITION is launching a mini-drama in China. We analyze why this signals a major shift from selling rooms to selling narratives.

With a fresh €1 billion from an oversubscribed bond sale, the French tech giant is doubling down on its vision to reshape industries with AI-powered virtual twins.

Wonga SA's top tech award signals a new era for short-term lending, using AI and alternative data to champion financial inclusion for millions in South Africa.

While ComEd’s massive storm response is a logistical victory, it serves as a stark preview of the multi-billion-dollar price tag for grid resilience.

A new BCG report reveals a dangerous gap: 96% of CMOs see AI as transformative, but only 8% use it autonomously. The race is on to close this divide.

With demand for AI compute outpacing supply, a new partnership aims to deliver purpose-built infrastructure across South Korea on an accelerated timeline.

HashKey Holdings plans a HKD100M share buyback, signaling deep confidence in its Web3 strategy despite a slumping stock price. What does this mean for investors?

Atossa Therapeutics secures a crucial capital lifeline. We dissect the deal, its impact on a promising cancer drug, and what it reveals about biotech funding today.

With a high-yield dividend and perfect rent collection, NewLake Capital signals stability. But is this cannabis REIT a safe haven or just a high-risk reward?

A $262,500 grant for a music festival seems simple, but it's an investment in a complex system. We explore how public funds fuel Montréal's cultural identity, economic vitality, and a greener future.

Cincinnati's baseball team partners with Avocados From Peru in a strategic play that goes beyond the ballpark, blending experiential marketing with healthy eating.

An $85M loan greenlights Beverly Hills' largest residential complex. But the real story is a decade of struggle, a key state law, and a city's future.

Australian biotech Gelteq has a gel that makes bitter medicine taste good to dogs. It's more than a pet owner's dream—it's a strategic move in a $47B market.

The precious metals miner appoints a new Chair and achieves 50% female board representation, signaling a strategic pivot to deepen its Moroccan growth.

EXL's new Gold Tier status with Databricks isn't just a partnership upgrade; it's a strategic move to solve AI's biggest business problem: data governance.

Momentus just secured another $25M, its second major cash infusion in weeks. Is this a desperate lifeline or a strategic launchpad for orbital dominance?

A landmark deal for CEL-SCI’s cancer drug Multikine in Saudi Arabia isn't just about a new market; it’s a case study in national ambition and biotech finance.

The Chinese insurtech's massive share consolidation is a desperate bid to stay on Nasdaq, but it reveals deeper struggles facing Chinese ADRs in the US.

As Madonna and Absolut partner for 'Confessions II,' we unpack the financial and cultural mechanics of a deal built on shared history and experiential marketing.

As Xtract One woos investors in Vegas, its AI security tech promises safety without sacrificing freedom. But can it scale its vision of a frictionless world?